HIV/AIDS
Researchers' work from University of California, U.S., adds to HIV/AIDS body of knowledge
Published in AIDS Weekly, February 5th, 2007
Study 1: Data detailed in "Valproic acid does not affect markers of human immunodeficiency virus disease progression" have been presented. According to recent research from the United States, "Valproic acid (VPA) reduces latent human immunodeficiency virus (HIV) reservoirs by activating resting CD4+ cells. This retrospective case-control study (n=30) examined effects of VPA on markers of HIV progression."
"VPA was not associated with changes in cerebrospinal fluid viral loads (VL), plasma VL, or neuropsychological performance. VPA patients had a trend towards lower...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2007-02-05)
More Articles from AIDS Weekly
- Drug Development
Viral Genetics identifies two key peptides for potential HIV/AIDS drug - HIV/AIDS Research
Grants aim to advance the understanding of rectal HIV transmission - HIV/AIDS
Scientists at Stanford University, Division of Infectious Diseases target HIV/AIDS in children - HIV/AIDS Cancer Gene Therapy
New HIV/AIDS cancer gene therapy research reported from Leiden University, Department of Molecular Cell Biology - HIV/AIDS Cancer Therapy
Study findings on HIV/AIDS cancer therapy are outlined in reports from International Agency for Research on Cancer - HIV/AIDS Co-Infection
Research results from University of California, Department of Neurology update knowledge of HIV/AIDS co-infection - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
